These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 19866239

  • 1. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes?
    Huang CW, Lin CY, Huang HY, Liu HW, Chen YJ, Shih DF, Chen HY, Juan CC, Ker CG, Huang CY, Li CF, Shiue YL.
    Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239
    [Abstract] [Full Text] [Related]

  • 2. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas.
    Huang HY, Kang HY, Li CF, Eng HL, Chou SC, Lin CN, Hsiung CY.
    Clin Cancer Res; 2006 Jan 15; 12(2):487-98. PubMed ID: 16428491
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
    Hashimoto N, Yachida S, Okano K, Wakabayashi H, Imaida K, Kurokohchi K, Masaki T, Kinoshita H, Tominaga M, Ajiki T, Ku Y, Okabayashi T, Hanazaki K, Hiroi M, Izumi S, Mano S, Okada S, Karasawa Y, Maeba T, Suzuki Y.
    Ann Surg Oncol; 2009 Feb 15; 16(2):395-403. PubMed ID: 19034576
    [Abstract] [Full Text] [Related]

  • 4. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
    Qin LF, Ng IO.
    Hum Pathol; 2001 Aug 15; 32(8):778-84. PubMed ID: 11521219
    [Abstract] [Full Text] [Related]

  • 5. Skp2 is an independent prognosticator of gallbladder carcinoma among p27(Kip1)-interacting cell cycle regulators: an immunohistochemical study of 62 cases by tissue microarray.
    Li SH, Li CF, Sung MT, Eng HL, Hsiung CY, Huang WW, Lin CN, Yu SC, Huang HY.
    Mod Pathol; 2007 Apr 15; 20(4):497-507. PubMed ID: 17384652
    [Abstract] [Full Text] [Related]

  • 6. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
    Koga H, Harada M, Ohtsubo M, Shishido S, Kumemura H, Hanada S, Taniguchi E, Yamashita K, Kumashiro R, Ueno T, Sata M.
    Hepatology; 2003 May 15; 37(5):1086-96. PubMed ID: 12717389
    [Abstract] [Full Text] [Related]

  • 7. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
    Zhao Y, Tang Q, Ni R, Huang X, Wang Y, Lu C, Shen A, Wang Y, Li C, Yuan Q, Chen H, Cheng C, He S.
    Hum Pathol; 2013 Mar 15; 44(3):365-73. PubMed ID: 22995332
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
    Bhatt KV, Hu R, Spofford LS, Aplin AE.
    Oncogene; 2007 Feb 15; 26(7):1056-66. PubMed ID: 16924241
    [Abstract] [Full Text] [Related]

  • 10. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression.
    Halfter H, Friedrich M, Resch A, Kullmann M, Stögbauer F, Ringelstein EB, Hengst L.
    Cancer Res; 2006 Jul 01; 66(13):6530-9. PubMed ID: 16818624
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma.
    Zhang SH, Qian YM, Liu AW, Cai J, Zhao XL, Wei JJ, Zhu MH.
    Hum Pathol; 2012 Jul 01; 43(7):1084-93. PubMed ID: 22204716
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer].
    Zheng XY, Ding W, Xie LP, Chen ZD.
    Ai Zheng; 2004 Feb 01; 23(2):215-8. PubMed ID: 14960249
    [Abstract] [Full Text] [Related]

  • 14. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance.
    Claudio PP, Russo G, Kumar CA, Minimo C, Farina A, Tutton S, Nuzzo G, Giuliante F, Angeloni G, Maria V, Vecchio FM, Campli CD, Giordano A.
    Clin Cancer Res; 2004 May 15; 10(10):3509-17. PubMed ID: 15161709
    [Abstract] [Full Text] [Related]

  • 15. [Expressions of Thr187 phosphorylated p27(kip1) and Skp2 proteins in human hepatocellular carcinomas and their significances].
    Wang Y, Chen L, Lu MD, Li P, Cui XP, Qin J, Shen AG.
    Zhonghua Gan Zang Bing Za Zhi; 2007 Dec 15; 15(12):943-4. PubMed ID: 18171537
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Jun activation domain binding protein 1 is overexpressed from the very early stages of hepatocarcinogenesis.
    Yachida S, Imaida K, Yokohira M, Hashimoto N, Suzuki S, Okano K, Wakabayashi H, Maeta H, Suzuki Y.
    Ann Surg Oncol; 2010 Dec 15; 17(12):3386-93. PubMed ID: 20589433
    [Abstract] [Full Text] [Related]

  • 18. Significance of skp2 expression in primary breast cancer.
    Sonoda H, Inoue H, Ogawa K, Utsunomiya T, Masuda TA, Mori M.
    Clin Cancer Res; 2006 Feb 15; 12(4):1215-20. PubMed ID: 16489076
    [Abstract] [Full Text] [Related]

  • 19. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
    Chen YL, Uen YH, Li CF, Horng KC, Chen LR, Wu WR, Tseng HY, Huang HY, Wu LC, Shiue YL.
    Ann Surg Oncol; 2013 Nov 15; 20(12):4041-54. PubMed ID: 22911364
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.